Case Study: IXICO achieves AIM listing and corporate brand elevation with Proi Worldwide

Ixico launches AIM listing and new dementia product with Proi Worldwide

Ixico Limited, a company specializing in innovative technologies for neurological diseases, faced the challenge of elevating its corporate brand and driving a major step change in its business ahead of its AIM listing and product commercialization. They approached Proi Worldwide for a fast-track marketing communications campaign to achieve this.

Proi Worldwide implemented a strategic process that included a brand articulation workshop and the design of a fully responsive website integrated with the London Stock Exchange. The results were significant; shortly after the launch, Ixico was acquired by Phytopharm Plc, which then changed its name to Ixico plc, and the combined business was admitted to AIM. Proi Worldwide continues to work with Ixico on an array of integrated marketing projects.

Ixico Limited